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uMMARY Clinical and serological folio\\'-ups \\'ere made on 18
children for 3 years and on another 18 children for + years,
BIKE\ IOCR\AL \. b1.19,115--118,1976
after Immunization against mumps by, attenuated mumps \, accine ;
Bikei\ vaccine. To evaluate the protective Gillcac\. of the \, accine,
matched controls \\, erc studied during the same period. Serological
examinations revealed that 771.1 of the vaccinees and 93'1, of the
controls were infected \\, Ith mumps after close contacts with mumps
patients. Regular mumps was contracted by 8811, of the controls,
but none of the vaccinees. There \\, as no substantial decrease in
the antibody, titers in unexposed vaccinees after vaccination
INTRODUCTION
The preceding paper of this series (ISOmura
et a1. , 1973) reported comparative studies on
clinical and serological responses after the ad-
ministrations of two different live mumps \, ac-
cines; Biken vaccine and ICrlyl-Lynn strain
Both vaccines \\. ere safe, causing no
clinical reactions and were highly jinmuno-
genic, resulting in neai'!y 1001, b seroconversion.
Ho\\ ever, the antibody, titers after vaccination
were considerably 10\\'CT than those after na-
tural Infection.
In the present study, clinical and serological
follow-ups were made on children three years
and four years after a single injection of Biken
To evaluate the efficacy of the vac-
cine, the attack rate of mumps among vac-





I. Pact!, Ie schcdi, /es
Two groups of seronegati\'e children in 1<, 151igai
City, Aichi Prefecture were tmmunized against
mumps with a single Injection of Biken \, accine
(Urube straiit of ntumps virus; Yamanishi at al. ,
1970; ISOmura at a1. , 1973): 18 children in the
autumn of 1971 and 18 children in the summer
of 1972. 'These children came from homes In
almost all areas of tlie cit\' and their SOCio-econo-
mical backgrounds \\ere also widel}' different. in
all, 31 of the 36 children showed successful I serocon-
version by both the hemagglutination inhibition (Hl)
test and neutralization test (NT) after vaccination
but in 5 children the Hl antibod\. titers were below
115
I5 at 6 \\, eeks after vaccination althotigh serocon-
version was demonstrated by the NT.
2. err"ic0/ 10/10?c-!, p o11 auct, ',, ees
Questionnaires \\ere sent once a year to parents
of \, accinees, to ascertain the frequency of contact
of vaccinees with mumps patients and the incidence
of mumps among the vaccinees. The extent of ex-
POSure and contraction of mumps were ascertained
by interviewing the n, others, at the time of blood
sampling.
3 . Nori"acc, '"ated rowtrol groi, p
Healthy children of ntatched ages were randomly
selected from the same residential areas in Kasugai
City. They were asked whether they, had come
in contact with cases of mumps and whether they
had contracted the disease during the period of
this study. Children who had been exposed to
mumps at before 3 years of ages were excluded,
because (1) all the vaccinees were jinmunized at
the age of 3 years old or more, (2) subclinical
Infections are frequently observed among young
children (ISOmura at al. , 1975). Thirty eight
children served as controls
RESULTS
I. He@"y, household contact group
Nine vaccinees and 10 control children were
exposed to mumps in family during the period.
Eight of the controls developed regular mumps,
but none of the vaccinees did. Serological
examination showed that all the vaccinees were
infected with because theirmumps virus,
antibody levels increased to almost the same
harel^ (g, om. t"it monn wine (GMV) of Hl
antibody titer: 2' ') as those of control child-
ren (CM\7 of Hl antib, dy titer^ 2' ') (Fig. I).
+. Collection and exa, ,findt, 'o11 o1 ser, ,,,, sri, ,, pies
Serum specimens were obtained from samples of
venous blood in the summer of 1975. The Hl
titers of sera \\ere measured as described previously.
(ISOmura et a1. , 1973)
5. Gi"d, }Ig of the exie"I of ftposi, ,'e to '11/1/11ps
The extent of exposure to ntumps was carefLilly
ascertained from mothers and classified as follows
(1) he a\,},, household contract group-children ex-
posed to cases of clinical ntumps in the family,
(2) indoor contact group-children who had come in
contact witlt cases of mumps in their class in kin-
dergarten or primary school, or with indoor play-
mates \\, ho It ad contracted mumps, (3) outdoor
contact group-children \\, hose mothers reported
mumps epidemics in their neighbourhood or in other
classes at school, but who had apparently not been
in direct contact with cases of mumps
Children whose mothers reported two or more
contacts with cases of mumps during the period























Years postv accinaiio n
FIGURE I. Results of clinical and serological ex-
aminations on children after intrafamiliar exposure.
Symbols : . , clinical infection after exposure ; 0,
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2. larcho, ' contact glowp
Among the 13 vaccinees in this group, 10
showed increases in antibody without develop-
ing clinical mumps after exposure. Among
the 15 controls, 14 exhibited increased anti-
body levels and I3 developed mumps after the
contact. There was no difference in the anti-
body titers of the vaccinees (CATV of Hl anti~
b. dy titer 2"" ") and control^ (GMV of Hl
antibody, titer: 2' ') after exposure,
spective of whether they developed clinical
mumps or not (Fig. 2)




























Years postvaccination,. e, "s
FIGURE 2. Results of clinical and setological ex-
aminations on children after Indoor contact. Svm-
bols : ., clinical infection after exposure ; 0 , no
clinical infectioit after exposure
3. Owldooi' COMtact g, o14p
Serological examinations showed that few
children \\. ere Infected \\, ith mumps as a result
of slight outdoor contact (Fig. 3). No vac-




it seems appropriate to exclude the children
in this group in evaluating vaccine efficacy,
because the rates of infection \\, ere 10\\, in both
groups (1112 in the \, accine group and 5113
11T controls).
4. One\posed growp
Two children had no contact \\, ith cases of
mumps in the first 3 years after vaccination.
Serologically, their antibody, activities re-














5. Relationshi/) belt, !eel! exte"I of expost, re ", Id
,,!/ectzo?! rate
After intrafamiliar exposure, all the children
in both groups experienced mumps virus In-
rection. In the indoor contact group, serologi-
cally confirmed infection \\, as recorded in 77'b
of the vaccinees and 93V, of the controls. In
contrast, very 10\\, infection rates were observed
in the light, outdoor contact group. Thus,
serological examination showed a direct cor-
relatioi\ between the extent of contact and the
infection rate (Table I).
TABLE I. Reintz'Dinship beltcee" extent of con-



















Veers POSlvEC Cinei;, n
FIGURE 3. Results of clinical and serological ex-
aminations on children after outdoor contact. Sym-
bols : . , clinical infection after exposure ; 0, no


























The safety and high jinmunogenicity of
Biken \, accine have been well documented









Clinical and serological follow-up studies \\, ere
carried out by Yamanishi at al. (Yamanishi
at a1. , 1971) on vaccinees. They reported that
(1) jinmunological studies showed no sub-
stantial decrease in the neutralizing antibody
titers in I }, ear and 3 years after vaccination,
(2) answers to mail questionnaires revealed the
high protective efficacy, of the vaccine. The
maintenance of antibody, titers and low rate
of clinical mumps among vaccinees \\. ere also
reported by other Investigators, using other
strains of attenuated mumps viruses (Dein-
hardt at a1. , 1969).
To confirm this excellent protective efficacy
of the vaccine, \\, e examined the attack rates
of mumps among vaccinated and nonvaccinated
children after exposure to the disease. As
seen in Table I and Fig. I, serological ex-
aminations showed that all of susceptible
siblings of cases of mumps were infected with
mumps virus and 80q, of the nonvaccinated
children subsequently developed regular
mumps. These findings are in good agree-
merit \\, ith past reports on the intrafamiliar
spread of mumps (A{ayer, 1962; ISOmura at
a1. , 1975). This high coinmunicability and
high attack rate were also observed among
susceptible children after indoor contact \\, ith
extrafamiliar cases of mumps (Table I and
Fig. 2).
In contrast, no vaccinees developed clinical
TABLE 2. Attack rote of Millmps amo"g sero-




infection after these types of contact (Table 2).
Thus, Biken vaccine had a clear protective
effect in these children.
Serologically, all the vaccinees showed in-
creased antibody titers after close contact \\, ith
cases of mumps. This high frequency, of a
booster effect may be due to the relatively 10\\
antibody, titers developed after vaccination.
No elevation of the antibody titers during the
period \\, as observed in U children in the
outdoor contact group or two unexposed child-
However, these children showed no ap-Ten.
preciable decrease in their antibody level.
Further follow-up studies on these children
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